- Feb 5, 2002
- 185,325
- 67,978
- Country
- United States
- Gender
- Female
- Faith
- Catholic
- Marital Status
- Married
- Politics
- US-Others
San Francisco-based startup Preventive has raised nearly $30 million from investors, including OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong, to develop embryo gene-editing technology aimed at preventing hereditary diseases.
The company, founded as a public benefit corporation, stated its goal is “to determine through rigorous preclinical work whether preventive gene editing can be developed safely to spare families from severe disease.”
Preventive co-founder and gene-editing scientist Lucas Harrington pledged to “not advance this technology to clinical human use if safety cannot be established through extensive research.”
“We will not compromise safety standards to accelerate timelines,” Harrington wrote.
Creating gene-edited babies is currently illegal in the United States, the United Kingdom, and most countries. Preventive is considering conducting clinical work in the United Arab Emirates, where embryo editing is not prohibited, according to The Wall Street Journal.
Continued below.
www.christianpost.com
The company, founded as a public benefit corporation, stated its goal is “to determine through rigorous preclinical work whether preventive gene editing can be developed safely to spare families from severe disease.”
Preventive co-founder and gene-editing scientist Lucas Harrington pledged to “not advance this technology to clinical human use if safety cannot be established through extensive research.”
“We will not compromise safety standards to accelerate timelines,” Harrington wrote.
Creating gene-edited babies is currently illegal in the United States, the United Kingdom, and most countries. Preventive is considering conducting clinical work in the United Arab Emirates, where embryo editing is not prohibited, according to The Wall Street Journal.
Continued below.
OpenAI CEO Sam Altman among investors in embryo gene-editing venture
San Francisco-based startup Preventive has raised nearly 30 million from investors, including OpenAI CEO Sam Altman and Coinbase CEO Brian Armstrong, to develop embryo gene-editing technology aimed
www.christianpost.com
